Recent studies from our own and other laboratories demonstrate that the number of C3b and C3bi receptors on the surface of human neutrophils increases when the cells are exposed to chemoattractants or other stimuli. We propose that this increase in complement receptor expression during neutrophil activation is an important response that is necessary for proper phagocytic activity. We plan to document the physiological significance of this phenomenon and to study the mechanism by which the number of receptors expressed on the cell surface increases. First, we will study neutrophils from inflammatory sites in vivo to demonstrate that they bear increased numbers of C3b and C3bi receptors using mnonoclonal antibodies and flow cytometry. We will correlate this with the ability of the cells to phagocytose complement coated particles. Next, we will analyze cells that may be deficient in receptor content or expression in similar studies of newborns' (cord blood) neutrophils. Both of these types of cells will be compared to control peripheral blood cells of normal donors. Our studies of the mechanisms by which the receptors are translocated from their intracellular pools to the surface wil focus on the hypothesis that receptor mobilization can occur independently from granular enzyme secretion. Teleologically, this would be advantageous as cells with optimal phagocytic activity would still contain important bactericidal proteins and enzymes in the granules. This will be studied by: 1) Correlating receptor expression with granular enzyume content of cells isolated from the sources described above as well as on normal cells incubated under conditions selected to effect one process but not the other. Receptor expression will be quantitated using monoclonal antibodies and flow cytometry as well as by radio-immunoassays. 2) Direct immunoelectron microscopic localization of receptors in permeabilized and sectioned cells before and during stimulation. 3) Localizing receptor protein pools in subcellular fractions of resting and activated cells. 4) Inducing the promyeloctic HL-60 cell line for granulocytic differentiation in vitro for studies of the order of appearance of surface C3b and C3bi receptors, intracellular receptor pools determining the fraction which will also be used for biosynthetic labelling studies to determine if protein modification accompanies receptor translocation. In addition to providing valuable information on the mechanism and significance of complement receptor expression, these studies should also yield important insights on the overall process of neutrophil activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022687-03
Application #
3134146
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1987-01-01
Project End
1989-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Chaudhuri, S; Kumar, A; Berger, M (2001) Association of ARF and Rabs with complement receptor type-1 storage vesicles in human neutrophils. J Leukoc Biol 70:669-76
Yoshida, Y; Kang, K; Berger, M et al. (1998) Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol 161:5873-9
Jost, C; Klickstein, L; Wetzler, E et al. (1998) Intracellular storage and regulated plasma membrane expression of human complement receptor type 1 in rat basophil leukemia cell transfectants. Blood 92:300-9
Kumar, A; Wetzler, E; Berger, M (1997) Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1. Blood 89:4555-65
Tosi, M F; Zakem-Cloud, H; Demko, C A et al. (1995) Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. J Infect Dis 172:453-61
Sengelov, H; Kjeldsen, L; Kroeze, W et al. (1994) Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils. J Immunol 153:804-10
Berger, M; Wetzler, E; August, J T et al. (1994) Internalization of type 1 complement receptors and de novo multivesicular body formation during chemoattractant-induced endocytosis in human neutrophils. J Clin Invest 94:1113-25
Berger, M (1991) Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? Clin Rev Allergy 9:119-42
Cowen, D S; Berger, M; Nuttle, L et al. (1991) Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines. J Leukoc Biol 50:109-22
Berger, M; Wetzler, E M; Welter, E et al. (1991) Intracellular sites for storage and recycling of C3b receptors in human neutrophils. Proc Natl Acad Sci U S A 88:3019-23

Showing the most recent 10 out of 18 publications